Author Archive
LABRHA at the ISIAT Congress in Prague in October 2017

LABRHA at the ISIAT Congress in Prague in October 2017

The 4th edition of the International Symposium on Intra-Articular Treatment (ISIAT) took place in Prague last 5th to 7th of October 2017. Organized every two years across different European cities by Prof. Alberto Migliore (IT), this congress is, as its name suggests, focus on intra-articular management of joint disease including intra-articular access, therapeutic targets and...
4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

2017 was no exception and after 3 successful editions, LABRHA organised last 07th and 08th of September 2017  its 4th LABRHA European Board on Viscosupplementation. 8 members of the EUROVISCO group participated this year. The group welcomed for this edition a new participant from Turkey, Prof. Demirhan Diracoglu, Physical Medicine and Rehabilitation specialist at the...
Viscosupplementation in the knee: 80% responders at 6 months with a single intra-articular injection of HAppyCross®

Viscosupplementation in the knee: 80% responders at 6 months with a single intra-articular injection of HAppyCross®

Results of an international study conducted in patients with knee OA A Franco-British work has been recently published in the Journal CARTILAGE(1) and presented at the 4th edition of the International Symposium on Intra-articular Treatment (ISIAT), which took place last 5th to 7th of October 2017. This work analysed the percentage of “responders”, 6 months...
Addition of a Polyol to HA: a Significant Advance in the Treatment of Osteoarthritis?

Addition of a Polyol to HA: a Significant Advance in the Treatment of Osteoarthritis?

Is the addition of a polyol to hyaluronic acid a significant advance in the treatment of osteoarthritis? Conrozier T. Curr Rheumatol Rev. 2017 Jul 10. doi:10.2174/1573397113666170710115558. Viscosupplementation with intra-articular injections of hyaluronic acid is recommended as a second line treatment for knee OA, after failure of non-pharmacological modalities and usual pain killers. Nevertheless there is...
LABRHA at the EULAR Congress in Madrid in June 2017

LABRHA at the EULAR Congress in Madrid in June 2017

LABRHA participated at the EULAR Congress, which took place from the 14th to the 17th of June 2017 in Madrid, and presented the very positive results of a study conducted on its product Fibromyalgine®, a phytotherapy solution designed for Fibromyalgia sufferers. The abstract MULTICENTER, PROSPECTIVE, CONTROLLED DOUBLE-BLIND STUDY COMPARING FIB-19-01 (FIBROMYALGINE®), A PHYTOTHERAPY TREATMENT FOR...